CRISPR Therapy Exceeds Targets in Thalassemia, Sickle Cell Disease Results "indicate that exa-cel can provide a one-time functional cure," says researcher Jun 13, 2023
FGFR Inhibitor Stakes Claim to Post-Anti-PD-1 Role in Advanced Bladder Cancer Survival benefit supports FGFR testing for all patients with metastatic disease, researcher says Jun 07, 2023
No Survival Benefit With Immune Checkpoint Inhibitor Rechallenge in Metastatic RCC The strategy also led to increased toxicity Jun 06, 2023
Neoadjuvant Chemo Flops Versus Upfront Surgery for Resectable Pancreatic Cancer Survival 13 months better with surgery, but "curiosities" in neoadjuvant arm muddy the results Jun 04, 2023
Novel Anti-HER2 Drugs 'Impressive' in Advanced Biliary Cancer Response rates reached 41-47% with different approaches in rare disease Jun 03, 2023
Adaptive RT Fails to Relieve Dry Mouth in Head and Neck Cancer "Expensive and intensive" process does not translate into clinical benefit, researchers conclude Jun 01, 2023
No Access to Routine Healthcare Biggest Barrier to HPV Vaccination Retrospective analysis shows vaccination rates haven't much improved for women since 2015 May 25, 2023
Medicaid Expansion Tied to Better Outcomes in Black Patients With GI Cancers Two-year mortality decreased for three types of GI cancer in expansion vs non-expansion states May 25, 2023
Less-Invasive Surgery for Pancreatic Cancer Proves Safe, Effective Radical resection rate noninferior to open surgery in early-stage disease, with similar survival May 25, 2023
Drug Shortages Hit Oncology; Telemedicine Tops In-Person; Sniffing Out Lung Cancer News, features, and commentary about cancer-related issues May 12, 2023
Adding This New Criteria Drastically Cut 72-Hour Insulinoma Fast Time Beta-hydroxybutyrate-based stopping point reduced burden on patients May 08, 2023
Even at Stage IV, Immunotherapy Helps in Pancreatic Cancer Small but clear boost to overall survival May 07, 2023
Food 'Swamps' Tied to Elevated Mortality From Obesity-Related Cancers Study suggests diet is not necessarily a modifiable risk factor for all, editorialists say May 05, 2023
Novel Chemo Delivery System Achieves High Response Rate in Bladder Cancer Complete responses in 73% of patients with BCG-unresponsive non-muscle-invasive disease May 02, 2023
Thriving After Cancer Tara Sanft, MD, on how clinicians can support patients through difficult times May 02, 2023 podcast
'Fantastic,' 'Terrific' Results With Oncolytic Virus Combo for Bladder Cancer Complete response rate of 85% in BCG-unresponsive non-muscle-invasive disease May 01, 2023
Sperm Donor Banned Over Incest Fears; COVID Hampered Teen Sex; Jerry Springer Dies Health news and commentary from around the Web gathered by 51³ΙΘΛΆ―Βώ staff Apr 28, 2023
Talc-Cancer Lawsuits on Hold; Diet & Prostate Cancer; Active Surveillance Deep Dive News, features, and commentary about cancer-related issues Apr 21, 2023
Awareness of HPV's Link to Cancer Lags as Cases Continue to Increase Clear decline for cervical cancer, awareness of other cancers remains stagnant Apr 21, 2023
Novel Bispecific Antibody Active in Recurrent/Metastatic Head and Neck Cancer Responses in 37% of patients previously treated with anti-PD-1/L1 agents, platinum chemotherapy Apr 18, 2023
Including Anti-PD-1 in First-Line Ups Survival in Biliary Tract Cancer Another option for difficult-to-treat disease Apr 17, 2023
Adjuvant Combo May Change Practice in High-Risk Liver Cancer Atezolizumab-bevacizumab reduced the risk of recurrence by about 30% Apr 17, 2023
Blood Donor's Sex Makes No Difference for Survival Only difference seen was higher incidence of MRSA infection in recipients of female donor blood Apr 12, 2023
Leading Causes of Death Hit Childhood Cancer Survivors Earlier But excess risk lowest in survivors with a healthy lifestyle Apr 06, 2023
CAR T-Cell Therapy Feasible, Safe in Advanced Neuroblastoma ORR of 63% with GD2-targeting product in kids with relapsed, refractory high-risk disease Apr 06, 2023
Major Survival Gain With Immunotherapy in Lymphomatoid Granulomatosis Median overall survival reached 20 years with interferon alfa-2b in low-grade disease Apr 05, 2023
FDA Greenlights New First-Line Regimen in Bladder Cancer Enfortumab vedotin plus pembrolizumab approved for cisplatin-ineligible patients Apr 04, 2023
Obesity's Impact on Uterine Cancer Risk Greater in Younger Age Groups Overall risk and risk of endometrioid subtype 20- to 30-fold greater in women younger than 35 Mar 30, 2023
A 'Double Whammy' for Gastric Cancer Risk H. pylori infection and certain pathogenic variants linked with large excess risk Mar 29, 2023
Phase III Trials 'Hit a Home Run' in Advanced Endometrial Cancer Adding immunotherapy will change frontline treatment, experts say Mar 28, 2023
No Survival Benefit With CRT Versus Chemo for Locally Advanced Endometrial Cancer Long-running clinical trial failed to identify any subgroup that fared better with CRT Mar 27, 2023
CRT Regimen Boosts Complete Response Rate in Unresectable Vulvar Cancer Pathologic response rises to 73% versus 50% in historical control group Mar 27, 2023
Cancer Transmission From Organ Donors With Brain Tumors Not Much of a Risk In U.K. cohort study, no cases of transmission observed Mar 22, 2023
Laparoscopy, Surgery in a Draw for Gastric Cancer Survival Laparoscopy-assisted distal gastrectomy noninferior for both relapse-free, overall survival Mar 15, 2023
A Space for Mystery Elisha Waldman, MD, discusses faith and spirituality in medicine Mar 07, 2023 podcast
These Surgeries Made the Sharpest Turns to Outpatient Setting After COVID Several procedures saw significant increases in outpatient volumes Mar 03, 2023
'Winners' and 'Losers'; Mandated Sick Leave and Cancer Screening; More AI Advances News, features, and commentary about cancer-related issues Mar 03, 2023
Cancer-Free Medicare Recipients Received Fentanyl Indicated for Cancer Pain These prescriptions could lead to abuse, OIG report warns Mar 02, 2023
Cancer Drugs That Didn't Work; Another HIV Cure; Kiss of Success With Mistletoe News, features, and commentary about cancer-related issues Feb 24, 2023
